FDA approves RSV drug

This fall, families will have a new option to protect babies from a virus that attacks the lungs called RSV. This new protection is different from what we're used to hearing about. It's not a vaccine, it's an antibody. Dr Mobeen Rathore, Chief of UF Health's Division of Pediatric Infectious Diseases and Immunology, explains how this antibody works to protect babies from getting RSV